Corrigendum to "Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19" [Vaccine 64 (2025) 127756]. - Almeida GG; Pinto JA; Pinto PM; da Silva LB; Andrade LAF; Valiate BVS; Zini N; Bagno FF; Rivelli GG; Lourenço KL; Souza JPC; Gomes IP; et al. (Vaccine, 2026)